Inflammation and Infection in Trauma, Role in Posttraumatic Complications
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00192907|
Recruitment Status : Unknown
Verified September 2005 by Rigshospitalet, Denmark.
Recruitment status was: Active, not recruiting
First Posted : September 19, 2005
Last Update Posted : September 19, 2005
Information provided by:
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Primary Completion Date :||No date given|
|Study Completion Date :||September 2005|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg. 2011 Aug;254(2):194-200. doi: 10.1097/SLA.0b013e318226113d.